Andrew Robbins
2022
In 2022, Andrew Robbins earned a total compensation of $4.4M as Chief Executive Officer at Cogent Biosciences, a 53% increase compared to previous year.
Compensation breakdown
| Bonus | $344,920 |
|---|---|
| Option Awards | $3,409,773 |
| Salary | $624,283 |
| Other | $12,200 |
| Total | $4,391,176 |
Robbins received $3.4M in option awards, accounting for 78% of the total pay in 2022.
Robbins also received $344.9K in bonus, $624.3K in salary and $12.2K in other compensation.
Rankings
In 2022, Andrew Robbins' compensation ranked 758th out of 5,760 executives tracked by ExecPay. In other words, Robbins earned more than 86.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 758 out of 5,760 | 87th |
Division Manufacturing | 339 out of 3,136 | 89th |
Major group Chemicals And Allied Products | 110 out of 1,422 | 92nd |
Industry group Drugs | 97 out of 1,323 | 93rd |
Industry Pharmaceutical Preparations | 72 out of 969 | 93rd |
Source: SEC filing on April 25, 2023.
Robbins' colleagues
We found two more compensation records of executives who worked with Andrew Robbins at Cogent Biosciences in 2022.